Y. Vlasova

Journey of a hematopoietic stem cell transplantation center through COVID-19 pandemic: one-year experience

L. Stelmakh, O. Goloshchapov, I. Moiseev, 2022, Cellular Therapy and Transplantation.

Long-term goals in the treatment of chronic graft-versus-host disease after matched allogeneic hematopoietic stem cell transplantation

I. Moiseev, B. Afanasyev, S. Bondarenko, 2020, Cellular Therapy and Transplantation.

First-line steroid-free systemic treatment of acute and chronic graft-versus-host disease after novel prophylaxis regimens

I. Moiseev, S. Bondarenko, A. Kulagin, 2022, Bone Marrow Transplantation.

Long-term outcomes of third-line therapy with tyrosine kinase inhibitors in chronic phase chronic myeloid leukemia: A real-life experience

S. Voloshin, V. Shuvaev, I. Martynkevich, 2023, Frontiers in Oncology.

Graft-versus-host disease prophylaxis with posttransplantation bendamustine (PTB) in patients with refractory acute leukemia: a dose-ranging study: Category of manuscript: Regular Manuscript.

E. Surkova, I. Moiseev, S. Bondarenko, 2021, Transplantation and cellular therapy.

Tyrosine kinase inhibitors: relapse prophylaxis after allogeneic hematopoietic stem cell transplantation in adults with Philadelphia chromosome-positive acute lymphoblastic leukemia

I. Moiseev, E. Bakin, S. Bondarenko, 2022, Cellular Therapy and Transplantation.